No Prescription |
 |
 | ||
|
TAVEGYL Anti Hist |
|
| ||
No Prescription » Prescription Drugs 15 » TAVEGYL Anti Hist Clemastine is used to relieve hay fever and allergy symptoms including sneezing; runny nose; and red itchy tearing eyes in adults and children older than 6 years of age. Prescription strength clemastine is also used to relieve the itching and swelling of hives in adults and children older than 6 years of age. Clemastine should not be used in children younger than 6 years old because it may cause serious or life-threatening side effects in young children. Clemastine should be used carefully in children who are 6-11 years old. Clemastine helps control symptoms of allergies and colds but does not treat the cause of these symptoms or speed recovery. Clemastine should not be used to cause sleepiness in children. Clemastine is in a class of medications called antihistamines. It works by blocking the action of histamine a substance in the body that causes allergic symptoms. Buy TAVEGYL Anti Hist and other Prescription Drugs 15 products online at Medstore. 594
About TAVEGYL Anti Hist: Product Type: Prescription Drugs 15 TAVEGYL ( Anti-Hist Tavist Tavist-1 Generic Clemastine ) TAVEGYL (Anti-Hist Tavist Tavist-1 Generic Clemastine) Anti-Hist Tavist Tavist-1 Generic Clemastine 1mg Tabs 30 ( 3 x10) Anti-Hist Tavist Tavist-1 Generic Clemastine TAVEGYL
View more Prescription Drugs 15 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
